Navigation Links
Discovery of genetic mutation in Leigh syndrome
Date:8/11/2009

This release is available in French.

Researchers at the Montreal Neurological Institute and Hospital (The Neuro), McGill University have discovered a genetic mutation underlying late-onset Leigh syndrome, a rare inherited metabolic disorder characterized by the degeneration of the central nervous system. The study published in Nature Genetics, provides vital insights into the cell biology of this neurological disorder and will lead to the development of diagnostic and predictive tests allowing for family and genetic counseling.

Leigh syndrome usually begins in early childhood and is caused by genetic mutations which result in mitochondrial dysfunction. Mitochondria are compartments in the cell which have their own DNA and function to supply energy to the body. Damage and dysfunction to mitochondrial DNA is a factor in more than 40 types of metabolic diseases and disorders, including Leigh syndrome. The first signs of the disorder are often poor sucking ability, loss of head control, and loss of acquired motor skills or movement. As the disorder progresses, symptoms may also include generalized weakness, lack of muscle tone, episodes of lactic acidosis (the body becomes more acidic than normal) and breathing problems. Death usually occurs within a few years. In rare cases, "late onset" Leigh syndrome begins during adolescence or early adulthood and progresses more slowly than the classical form. Currently, there is no cure and treatment is limited and not very effective.

"Defects in the protein production machinery, or translation, are among the most common causes of mitochondrial disease," says Dr. Eric Shoubridge, neuroscientist at The Neuro and lead investigator in the study, "and the mechanisms that regulate translation have until now remained largely unknown."

"Using molecular biological techniques and DNA analysis, we were able to pin point a mutation in the TACO1 gene which encodes a translational activator important for the proper production of a protein called COX1. This study is also the first to identify a protein of this nature in humans.COX1 is a critical component of one of the enzymes in the energy production pathway in cells, and disruptions in COX1 production, lead to loss of enzyme activity and the symptoms in Leigh Syndrome."

Researchers in Dr. Shoubridge's lab at The Neuro were the first to discover the gene implicated in the most common form of Leigh syndrome and are now studying various forms of the disease. This includes the French-Canadian form common in the Saguenay-Lac St-Jean region of Quebec which is associated with a different genetic mutation, but the same biochemical defect, and similar presentation to the form investigated in this study. Neuro researchers are also collaborating on Le Grand Defi led by Pierre Lavoie, an initiative to raise awareness and funds for research into the disease.


'/>"/>

Contact: Anita Kar
anita.kar@mcgill.ca
514-398-3376
McGill University
Source:Eurekalert

Related biology news :

1. Discovery to aid in future treatments of third-world parasites
2. New discovery suggests trees evolved camouflage defense against long extinct predator
3. Down Under dinosaur burrow discovery provides climate change clues
4. GUMC discovery highlights new direction for drug discovery
5. Discovery may provide new treatments for alcohol dependence
6. New nanoparticles could revolutionize therapeutic drug discovery
7. Discovery of a water snake that startles fish in a way that makes them flee into its jaws
8. New discovery suggests mammoths survived in Britain until 14,000 years ago
9. Discovery of the cells water gate may lead to new cancer drugs
10. Aussie and Kiwi researchers make double MS genetic discovery
11. Discovery raises new doubts about dinosaur-bird links
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... , April 5, 2017 Today HYPR ... that the server component of the HYPR platform is ... providing the end-to-end security architecture that empowers biometric authentication ... HYPR has already secured over 15 million users across ... manufacturers of connected home product suites and physical access ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
Breaking Biology News(10 mins):
(Date:4/27/2017)...  Pendant Biosciences, Inc. (formerly Nanoferix, Inc.), a privately-held ... delivery technologies, today announced that it has been accepted ... Toronto . Shawn Glinter , ... "We are excited to become part of the JLABS ... honored to be the first Tennessee ...
(Date:4/26/2017)... Alto, CA, USA (PRWEB) , ... April 26, ... ... popular seminar on FDA’s GMP expectations for phase I clinical trials comes to ... attended by various biotechnology and pharma professionals representing FDA regulated organizations such as ...
(Date:4/26/2017)... ... April 26, 2017 , ... As the call for ... industry stakeholders, the discussion surrounding the topic will continue at WEDI 2017- Driving ... Los Angeles, Calif. Hosted by the Workgroup for Electronic Data Interchange (WEDI), the ...
(Date:4/25/2017)... ... April 25, 2017 , ... L3 Clinical ... announce the company is now a certified iMedNet eClinical and Electronic Data Capture ... the company’s clinical research team to build, customize and manage clinical trial data ...
Breaking Biology Technology: